Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Stöger H[au]:

Management of HER2-Positive Early Breast Cancer. Steger G et al. Breast Care (Basel). (2018)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients. Terbuch A et al. Int J Mol Sci. (2018)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Posch F et al. Oncoimmunology. (2018)

Search results

Items: 1 to 50 of 94

1.

End-of-life decision making by Austrian physicians - a cross-sectional study.

Jahn-Kuch D, Domke A, Bitsche S, Stöger H, Avian A, Jeitler K, Posch N, Siebenhofer A.

BMC Palliat Care. 2020 Jan 4;19(1):4. doi: 10.1186/s12904-019-0509-3.

2.

Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.

Smolle MA, Sande MV, Callegaro D, Wunder J, Hayes A, Leitner L, Bergovec M, Tunn PU, van Praag V, Fiocco M, Panotopoulos J, Willegger M, Windhager R, Dijkstra SPD, van Houdt WJ, Riedl JM, Stotz M, Gerger A, Pichler M, Stöger H, Liegl-Atzwanger B, Smolle J, Andreou D, Leithner A, Gronchi A, Haas RL, Szkandera J.

Cancers (Basel). 2019 Dec 21;12(1). pii: E47. doi: 10.3390/cancers12010047.

3.

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.

PMID:
31570454
4.

Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.

Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M.

Clin Genitourin Cancer. 2019 Oct;17(5):e957-e967. doi: 10.1016/j.clgc.2019.05.017. Epub 2019 May 25.

5.

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.

Posch F, Ay C, Stöger H, Kreutz R, Beyer-Westendorf J.

Res Pract Thromb Haemost. 2019 Mar 5;3(2):207-216. doi: 10.1002/rth2.12189. eCollection 2019 Apr.

6.

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F.

Sci Rep. 2019 Apr 3;9(1):5548. doi: 10.1038/s41598-019-42069-1.

7.

Management of HER2-Positive Early Breast Cancer.

Steger G, Lüftner D, Stöger H, Thürlimann B, Untch M.

Breast Care (Basel). 2018 Dec;13(6):453-455. doi: 10.1159/000494945. Epub 2018 Dec 5. No abstract available.

8.

Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.

Posch F, Ay C, Stöger H, Kreutz R, Beyer-Westendorf J.

Int J Cardiol. 2019 May 1;282:47-52. doi: 10.1016/j.ijcard.2019.01.089. Epub 2019 Jan 27.

PMID:
30777405
9.

Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.

Barth DA, Riedl JM, Posch F, Smolle MA, Kasparek AK, Niedrist T, Szkandera J, Stöger H, Pichler M, Stotz M, Gerger A.

Clin Transl Oncol. 2019 Aug;21(8):1034-1043. doi: 10.1007/s12094-019-02037-7. Epub 2019 Jan 22.

PMID:
30671731
10.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

11.

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.

Asamer E, Szkandera J, Gibiser P, Lembeck AL, Stojakovic T, Kornprat P, Lackner C, Winder T, Schlick K, Stöger H, Gerger A, Pichler M, Stotz M.

Wien Klin Wochenschr. 2018 Oct;130(19-20):569-574. doi: 10.1007/s00508-018-1383-3. Epub 2018 Aug 21.

12.

Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.

Smolle MA, van Praag VM, Posch F, Bergovec M, Leitner L, Friesenbichler J, Heregger R, Riedl JM, Pichler M, Gerger A, Szkandera J, Stöger H, Smolle-Jüttner FM, Liegl-Atzwanger B, Fiocco M, van de Sande MA, Leithner A.

Eur J Surg Oncol. 2019 Feb;45(2):242-248. doi: 10.1016/j.ejso.2018.06.019. Epub 2018 Jul 3.

PMID:
30031674
13.

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.

Posch F, Silina K, Leibl S, Mündlein A, Moch H, Siebenhüner A, Samaras P, Riedl J, Stotz M, Szkandera J, Stöger H, Pichler M, Stupp R, van den Broek M, Schraml P, Gerger A, Petrausch U, Winder T.

Oncoimmunology. 2017 Dec 18;7(2):e1378844. doi: 10.1080/2162402X.2017.1378844. eCollection 2018.

14.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M.

Cancer Med. 2018 Feb;7(2):508-514. doi: 10.1002/cam4.1317. Epub 2018 Jan 19.

15.

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.

Riedl JM, Posch F, Moik F, Bezan A, Szkandera J, Smolle MA, Kasparek AK, Pichler M, Stöger H, Stotz M, Gerger A.

Oncotarget. 2017 Oct 4;8(56):96048-96061. doi: 10.18632/oncotarget.21647. eCollection 2017 Nov 10.

16.

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.

Posch F, Partl R, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J.

Ann Surg Oncol. 2018 Mar;25(3):776-783. doi: 10.1245/s10434-017-6080-3. Epub 2017 Sep 11.

17.

Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.

Prochazka KT, Posch F, Deutsch A, Beham-Schmid C, Stöger H, Abdyli L, Greinix H, Pichler M, Neumeister P.

Br J Haematol. 2018 Oct;183(1):142-146. doi: 10.1111/bjh.14912. Epub 2017 Sep 6. No abstract available.

PMID:
28875547
18.

Long-term cardiovascular complications in stage I seminoma patients.

Terbuch A, Posch F, Annerer LM, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Gerger A, Stotz M.

Clin Transl Oncol. 2017 Nov;19(11):1400-1408. doi: 10.1007/s12094-017-1742-y. Epub 2017 Aug 29.

19.

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.

Riedl JM, Posch F, Bezan A, Szkandera J, Smolle MA, Winder T, Rossmann CH, Schaberl-Moser R, Pichler M, Stotz M, Stöger H, Gerger A.

BMC Cancer. 2017 Jun 15;17(1):415. doi: 10.1186/s12885-017-3392-4.

20.

Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.

Stotz M, Herzog SA, Pichler M, Smolle M, Riedl J, Rossmann C, Bezan A, Stöger H, Renner W, Berghold A, Gerger A.

Anticancer Res. 2017 Apr;37(4):2011-2018.

PMID:
28373475
21.

Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

Posch F, Leitner L, Bergovec M, Bezan A, Stotz M, Gerger A, Pichler M, Stöger H, Liegl-Atzwanger B, Leithner A, Szkandera J.

Clin Orthop Relat Res. 2017 May;475(5):1427-1435. doi: 10.1007/s11999-017-5232-x. Epub 2017 Jan 12.

22.

Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.

Brämswig K, Ploner F, Martel A, Bauernhofer T, Hilbe W, Kühr T, Leitgeb C, Mlineritsch B, Petzer A, Seebacher V, Stöger H, Girschikofsky M, Hochreiner G, Ressler S, Romeder F, Wöll E, Brodowicz T.

Anticancer Drugs. 2014 Aug;25(7):848-53. doi: 10.1097/CAD.0000000000000108.

PMID:
24667659
23.

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2014 Mar 1;20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

24.

[Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].

Stöger H.

Dtsch Med Wochenschr. 2013 Oct;138(41):2096. doi: 10.1055/s-0033-1349531. Epub 2013 Oct 1. German. No abstract available.

PMID:
24085364
25.

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.

Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R.

Br J Cancer. 2013 Aug 6;109(3):589-96. doi: 10.1038/bjc.2013.367. Epub 2013 Jul 18.

26.

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.

Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M; ABCSG.

Br J Cancer. 2013 Apr 16;108(7):1408-14. doi: 10.1038/bjc.2013.114. Epub 2013 Mar 19.

27.

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival.

Gary T, Belaj K, Steidl K, Pichler M, Eisner F, Stöger H, Hafner F, Froehlich H, Samonigg H, Pilger E, Brodmann M.

Br J Cancer. 2012 Oct 9;107(8):1244-8. doi: 10.1038/bjc.2012.401. Epub 2012 Sep 11.

28.

The ethics of space, design and color in an oncology ward.

Andritsch E, Stöger H, Bauernhofer T, Andritsch H, Kasparek AK, Schaberl-Moser R, Ploner F, Samonigg H.

Palliat Support Care. 2013 Jun;11(3):215-21. doi: 10.1017/S1478951512000077. Epub 2012 Aug 10.

PMID:
22883931
29.

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M.

J Clin Oncol. 2012 Mar 1;30(7):722-8. doi: 10.1200/JCO.2011.36.8993. Epub 2012 Jan 23.

PMID:
22271481
30.

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2008 Apr 1;14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.

31.

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.

Friess H, Langrehr JM, Oettle H, Raedle J, Niedergethmann M, Dittrich C, Hossfeld DK, Stöger H, Neyns B, Herzog P, Piedbois P, Dobrowolski F, Scheithauer W, Hawkins R, Katz F, Balcke P, Vermorken J, van Belle S, Davidson N, Esteve AA, Castellano D, Kleeff J, Tempia-Caliera AA, Kovar A, Nippgen J.

BMC Cancer. 2006 Dec 11;6:285.

32.

Smoking, cereal consumption, and supplementation affect cadmium content in breast milk.

Gundacker C, Pietschnig B, Wittmann KJ, Salzer H, Stöger H, Reimann-Dorninger G, Schuster E, Lischka A.

J Expo Sci Environ Epidemiol. 2007 Jan;17(1):39-46. Epub 2006 Sep 6.

PMID:
16955091
33.

Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.

Bjelic-Radisic V, Stöger H, Winter R, Beham-Schmid C, Petru E.

Anticancer Res. 2006 Mar-Apr;26(2B):1627-30.

34.

The nasal bone in fetuses with trisomy 21: sonographic versus pathomorphological findings.

Minderer S, Gloning KP, Henrich W, Stöger H.

Ultrasound Obstet Gynecol. 2003 Jul;22(1):16-21.

35.

[Guideline of the Austrian Society of Gynecology and Obstetrics on suspected sexual offenses. November 2001 status].

Loimer L, Bichler A, Brezinka C, Brown A, Denk W, Friedrich E, Hohenbichler U, Mayerhofer K, Rieger A, Schaffer M, Spacek K, Stadlbauer G, Stöger H, Vytiska-Binsdorfer E, Pateisky N.

Wien Klin Wochenschr. 2002 Mar 28;114(5-6):233-5. German. No abstract available.

PMID:
12238315
36.

Seminoma metastases mimicking primary pancreatic cancer.

Wehrschütz M, Stöger H, Ploner F, Hofmann G, Wolf G, Höfler G, Krippl P, Samonigg H.

Onkologie. 2002 Aug;25(4):371-3.

PMID:
12232490
37.

[Teutschländer disease. A rare benign differential diagnosis in proliferating space-occupying lesions of soft tissues].

Kuchenbauer F, Biberthaler P, Stöger H, Mutschler W.

Unfallchirurg. 2002 Jun;105(6):572-5. German.

PMID:
12132199
38.

Overproduction of a functional A1 ATPase from the archaeon Methanosarcina mazei Gö1 in Escherichia coli.

Lemker T, Ruppert C, Stöger H, Wimmers S, Müller V.

Eur J Biochem. 2001 Jul;268(13):3744-50.

39.

Adjuvant radiotherapy in male breast cancer.

Stranzl H, Mayer R, Quehenberger F, Prettenhofer U, Willfurth P, Stöger H, Hackl A.

Radiother Oncol. 1999 Oct;53(1):29-35.

PMID:
10624850
40.

Combined treatment of metastatic osteosarcoma of the spine.

Bauernhofer T, Stöger H, Kasparek AK, Ploner F, Kuss I, Pieber TR, Kotz R, Samonigg H.

Oncology. 1999 Nov;57(4):265-8. Review.

PMID:
10575309
41.

A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.

Samonigg H, Wilders-Truschnig M, Kuss I, Plot R, Stöger H, Schmid M, Bauernhofer T, Tiran A, Pieber T, Havelec L, Loibner H.

J Immunother. 1999 Nov;22(6):481-8.

PMID:
10570746
42.

How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance.

Biesenbach G, Grafinger P, Stöger H, Zazgornik J.

J Nephrol. 1999 Jan-Feb;12(1):41-6.

PMID:
10203003
43.

Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor.

Stöger H, Samonigg H, Krainer M, Ploszczynski M, Nirnberger G, Maca S, Hehenwarter W, Wirth M, Schüller J, Vavra N, Scheithauer W, Kornek G, Stierer M, Zielinski CC.

Eur J Cancer. 1998 Mar;34(4):482-8.

PMID:
9713297
44.

Coronary embolization in a woman with advanced breast cancer.

Watzinger N, Stöger H, Ratschek M.

N Engl J Med. 1997 Apr 10;336(15):1104-5. No abstract available.

PMID:
9091816
45.

Sequential treatment of recurrent mesenteric desmoid tumor.

Bauernhofer T, Stöger H, Schmid M, Smola M, Gürtl-Lackner B, Höfler G, Ranner G, Reisinger E, Samonigg H.

Cancer. 1996 Mar 15;77(6):1061-5. Review.

PMID:
8635124
46.

Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.

Schmid M, Samonigg H, Stöger H, Auer H, Sternthal MH, Wilders-Truschnig M, Reisinger EC.

Clin Infect Dis. 1995 Jun;20(6):1543-6.

PMID:
7548507
47.

Laparoscopic diagnosis of peritoneal serous papillary carcinoma.

Trauner M, Klimpfinger M, Stauber RE, Schreiber F, Stöger H, Krejs GJ.

Endoscopy. 1995 May;27(4):337-41.

PMID:
7555942
48.

A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.

Stöger H, Schmid M, Bauernhofer T, Moser R, Ploner F, Derstvenscheg E, Kasparek AK, Kuss I, Wilders-Truschnig M, Lackner C, et al.

Oncology. 1994 Nov-Dec;51(6):518-22.

PMID:
7970497
49.

Abnormal increases in urinary albumin excretion during pregnancy in IDDM women with pre-existing microalbuminuria.

Biesenbach G, Zazgornik J, Stöger H, Grafinger P, Hubmann R, Kaiser W, Janko O, Stuby U.

Diabetologia. 1994 Sep;37(9):905-10.

PMID:
7806020
50.

[Scurvy after a suicide attempt by starvation].

Stöger H, Wilders-Truschnig M, Schmid M, Petek W, Samonigg H.

Dtsch Med Wochenschr. 1994 Apr 22;119(16):589-92. German.

PMID:
8162842

Supplemental Content

Loading ...
Support Center